Citations

Citations to this article as recorded by  

• Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
  Priscilla Francesca Procopio, Francesco Pennestrì, Nikolaos Voloudakis, Stefania La Rocca, Pierpaolo Gallucci, Esther Diana Rossi, Carmela De Crea, Marco Raffaelli
  Surgery.2025; 177: 108881.     CrossRef
• Thyrotoxicosis With Medullary Thyroid Carcinoma: A Rare Endocrine Diagnostic Challenge
  G Balamurugan, N Selvaraj, Sahana Kannan
  Cureus.2025;[Epub]     CrossRef
• Simultaneous Medullary and Papillary Thyroid Carcinomas: Personal Experience Report and Literature Review
  Nadia De Falco, Massimo Agresti, Massimo De Falco, Pasquale Sperlongano, Giancarlo Moccia, Pasquale Luongo, Alessio Cece, Francesco Bove, Francesco Miele, Alfredo Allaria, Francesco Torelli, Paola Bassi, Antonella Sciarra, Stefano Avenia, Paola Della Moni
  Journal of Clinical Medicine.2025; 14(4): 1382.     CrossRef
• Synchronous thyroid medullary cancer and thyroid hemiagenesis: A case report
  Chunyang Li, Chengbin Zhang, Chao Ma, Yonghui Wang, Quanhong Duan
  Experimental and Therapeutic Medicine.2025; 29(4): 1.     CrossRef
• Diagnosis and treatment of a rare bilateral primary thyroid cancer: a case report
  Hai Lin, Xinyu Zhang, Na Yan, Tao Guo, Qiu Chen, Xianen Huang, Dandan Wang, Weili Wu
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Celastrol promotes apoptotic cell death in thyroid cancer cells through a caspases-dependent pathway
  Ruoyi Yang, Jie Yao, Hong Ma, Chunyan Shui, Teng Li, Sicheng Zhang, Chao Li
  Thyroid Research.2025;[Epub]     CrossRef
• Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
  Yuxin Shen, Fengsheng Hong, Hualu Wu, Xiaohai Chen, Hailun Xia, Ren-ai Xu, Guanyang Lin, Lu Shi
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Molecular oncology of iodine refractory thyroid cancer current therapies and perspective
  François Cherifi, Ahmad Awada
  Critical Reviews in Oncology/Hematology.2025; 209: 104679.     CrossRef
• Photodynamic Therapy for Thyroid Cancer
  Julia Inglot, Joanna Katarzyna Strzelczyk, Dorota Bartusik-Aebisher, David Aebisher
  BioMed.2025; 5(1): 8.     CrossRef
• The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs
  Sara Gil-Bernabé, Lucía García-DeLaFuente, Ginesa García-Rostán
  International Journal of Molecular Sciences.2025; 26(8): 3663.     CrossRef
• A case of medullary thyroid carcinoma with “Spongiform” nodule appearance on ultrasound
  Xue-Yang Ji, Zeng-Gang Hu, Ke-Xiao Mu, Nian-Yu Xue
  Asian Journal of Surgery.2025;[Epub]     CrossRef
• Test di funzionalità tiroidea
  A. Charon, F. Bonnet-Serrano, C. Buffet
  EMC - AKOS - Trattato di Medicina.2025; 27(2): 1.     CrossRef
• The diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists
  Marc P. Pusztaszeri, Zahra Maleki
  Cancer Cytopathology.2025;[Epub]     CrossRef
• Medullary Thyroid Cancer Discovered Through Elevated Carcinoembryonic Antigen Levels Post Colorectal Cancer Resection
  Andrew Glaza, Jeffrey Margolis
  Annals of Internal Medicine: Clinical Cases.2025;[Epub]     CrossRef
• Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities
  Alessio Imperiale, Valentina Berti, Mickaël Burgy, Roberto Luigi Cazzato, Arnoldo Piccardo, Giorgio Treglia
  Reviews in Endocrine and Metabolic Disorders.2024; 25(1): 187.     CrossRef
• Diffuse C-Cells Hyperplasia Is the Source of False Positive Calcitonin Measurement in FNA Washout Fluids of Thyroid Nodules: A Rational Clinical Approach to Avoiding Unnecessary Surgery
  Chiara Mura, Rossella Rodia, Silvia Corrias, Antonello Cappai, Maria Letizia Lai, Gian Luigi Canu, Fabio Medas, Pietro Giorgio Calò, Stefano Mariotti, Francesco Boi
  Cancers.2024; 16(1): 210.     CrossRef
• Meta-Analysis of the Efficacy and Safety Evaluation of Vandetanib in the Treatment of Medullary Thyroid Cancer
  Tong-cheng Xian, Min-ye Yang, Xue-lin Zhang, Jie Wang, Yi Luo
  Hormone and Metabolic Research.2024; 56(09): 649.     CrossRef
• Successful localisation of recurrent thyroid cancer using preoperative patent blue dye injection
  B. O. Evranos, N. Ince, H. Ataş, S. B. Polat, H. Ahsen, N. N. Imga, A. Dirikoc, O. Topaloglu, T. Tutuncu, R. Ersoy, B. Cakir
  Journal of Endocrinological Investigation.2024; 47(8): 1941.     CrossRef
• Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials
  Ke Wang, Ying Zhang, Yang Xing, Hong Wang, Minghua He, Rui Guo
  Discover Oncology.2024;[Epub]     CrossRef
• Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer
  Zhiqiang Liu, Xiwei Zhang, Xiaohui Zhao, Qianqian Guo, Zhengjiang Li, Minghui Wei, Lijuan Niu, Changming An
  BMC Medical Imaging.2024;[Epub]     CrossRef
• Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
  Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, Sargol Gohari, Mehdi Dadashpour
  Cell Communication and Signaling.2024;[Epub]     CrossRef
• Diagnostic capabilities of PET/CT with ¹⁸F-DOPA in biochemical recurrence of medullary thyroid carcinoma: a retrospective study
  N. V. Tsentr, A. A. Zyryanova, M. A. Rusnak, D. V. Ryzhkova
  Diagnostic radiology and radiotherapy.2024; 15(1): 87.     CrossRef
• LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1
  Daxiang Liu, Wenjing Wang, Yanzhao Wu, Yongle Qiu, Lan Zhang
  Current Cancer Drug Targets.2024; 24(5): 519.     CrossRef
• Spontaneous and Treatment-Related Changes of Serum Calcitonin in Medullary Thyroid Cancer: Long-Term Experience in a Patient With Multiple Endocrine Neoplasia Type 2B
  Zsuzsanna Réti, Ádám Gy. Tabák, Miklós Garami, Ildikó Kalina, Gergely Kiss, Zoltán Sápi, Miklós Tóth, Judit Tőke
  JCO Precision Oncology.2024;[Epub]     CrossRef
• False-Negative 68Ga-FAPI PET/CT in Pediatric Thyroid Medullary Carcinoma Seen With 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT
  Mohamad B. Haidar, Farah A. Abou Zeid, Zarouhie Z. Meguerian, Akram N. Al-Ibraheem, Peter E. Noun
  Clinical Nuclear Medicine.2024; 49(7): 690.     CrossRef
• B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma
  Pengtao Song, Yongcan Xu, Guochao Ye
  Diagnostic Pathology.2024;[Epub]     CrossRef
• Medullary thyroid carcinoma with ACHT-dependent Cushing's syndrome: Therapeutic possibilities
  Dušan Ilić, Sanja Ognjanović, Bojana Popović, Valentina Elezović-Kovačević, Milica Opalić-Palibrk, Lena Radić, Katarina Krstić, Đuro Macut
  Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma.2024; 29(93): 46.     CrossRef
• Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single center
  Bin Liu, Ying Peng, Yanjun Su, Chang Diao, Ruochuan Cheng
  Endocrine.2024; 86(3): 1081.     CrossRef
• Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues
  Salvatore Raia, Sabrina Chiloiro, Antonella Giampietro, Maria Grazia Maratta, Fabia Attili, Maria Gabriella Brizi, Vittoria Rufini, Laura De Marinis, Alfredo Pontecorvi, Guido Rindi, Giovanni Schinzari, Antonio Bianchi
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2024; 24(12): 1464.     CrossRef
• Holomics and Artificial Intelligence-Driven Precision Oncology for Medullary Thyroid Carcinoma: Addressing Challenges of a Rare and Aggressive Disease
  Thifhelimbilu Emmanuel Luvhengo, Maeyane Stephens Moeng, Nosisa Thabile Sishuba, Malose Makgoka, Lusanda Jonas, Tshilidzi Godfrey Mamathuntsha, Thandanani Mbambo, Shingirai Brenda Kagodora, Zodwa Dlamini
  Cancers.2024; 16(20): 3469.     CrossRef
• GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges
  Patrycja Kupnicka, Małgorzata Król, Justyna Żychowska, Ryszard Łagowski, Eryk Prajwos, Anna Surówka, Dariusz Chlubek
  Pharmaceuticals.2024; 17(11): 1470.     CrossRef
• DLK1 Is Associated with Stemness Phenotype in Medullary Thyroid Carcinoma Cell Lines
  Danilo Dias da Silva, Rodrigo Pinheiro Araldi, Mariana Rocha Belizario, Welbert Gomes Rocha, Rui Monteiro de Barros Maciel, Janete Maria Cerutti
  International Journal of Molecular Sciences.2024; 25(22): 11924.     CrossRef
• Prognosis analysis and nomogram for predicting lateral lymph node metastasis in Medullary Thyroid Microcarcinoma
  Jinming Zhang, Dongmei Huang, Ming Gao, Xiangqian Zheng
  Langenbeck's Archives of Surgery.2024;[Epub]     CrossRef
• Distinct Impacts of Clinicopathological and Mutational Profiles on Long-Term Survival and Recurrence in Medullary Thyroid Carcinoma
  Moon Young Oh, Kyong Yeun Jung, Hoonsung Choi, Young Jun Chai, Sun Wook Cho, Su-jin Kim, Kyu Eun Lee, Eun-Jae Chung, Do Joon Park, Young Joo Park, Han-Kwang Yang
  Endocrinology and Metabolism.2024; 39(6): 877.     CrossRef
• Incidental diagnosis of medullary thyroid microcarcinoma in COVID-19 patient with elevated procalcitonin levels
  Milka Jandric, Biljana Zlojutro , Dragoș Crețoiu
  Archive of Clinical Cases.2024; 11(4): 98.     CrossRef
• Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine
  Giorgio Treglia, Vittoria Rufini, Arnoldo Piccardo, Alessio Imperiale
  Seminars in Nuclear Medicine.2023; 53(4): 481.     CrossRef
• Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
  Linnea Højer Wang, Markus Wehland, Petra M. Wise, Manfred Infanger, Daniela Grimm, Michael C. Kreissl
  International Journal of Molecular Sciences.2023; 24(3): 2312.     CrossRef
• A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratio
  Pengfei Xu, Di Wu, Xuekui Liu
  Endocrine.2023; 81(1): 107.     CrossRef
• Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literatur
  Marianna Hertelendi, Oulaya Belguenani, Azzeddine Cherfi, Ilya Folitar, Gabor Kollar, Berna Degirmenci Polack
  Biomedicines.2023; 11(4): 1024.     CrossRef
• PET/CT with various radiopharmaceuticals in the complex diagnosis of medullary thyroid carcinoma: a review
  N. V. Tsentr, A. E. Ertman, D. V. Ryzhkova
  Diagnostic radiology and radiotherapy.2023; 14(2): 31.     CrossRef
• Physical activity and reduced risk of fracture in thyroid cancer patients after thyroidectomy — a nationwide cohort study
  Jinyoung Kim, Kyungdo Han, Jin-Hyung Jung, Jeonghoon Ha, Chaiho Jeong, Jun-Young Heu, Se-Won Lee, Jeongmin Lee, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Ki-Hyun Baek
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Different RONS Generation in MTC-SK and NSCL Cells Lead to Varying Antitumoral Effects of Alpha-Ketoglutarate + 5-HMF
  Joachim Greilberger, Katharina Erlbacher, Philipp Stiegler, Reinhold Wintersteiger, Ralf Herwig
  Current Issues in Molecular Biology.2023; 45(8): 6503.     CrossRef
• Medullary thyroid carcinoma
  Maria Rosa Pelizzo, Esmeralda Isabella Mazza, Caterina Mian, Isabella Merante Boschin
  Expert Review of Anticancer Therapy.2023; 23(9): 943.     CrossRef
• Mixed medullary‑follicular thyroid carcinoma: A case report and literature review
  Yonghui Wang, Dandan Yin, Guifang Ren, Zhengjiang Wang, Fanhua Kong
  Oncology Letters.2023;[Epub]     CrossRef
• Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
  Anna Citarella, Zein Mersini Besharat, Sofia Trocchianesi, Tanja Milena Autilio, Antonella Verrienti, Giuseppina Catanzaro, Elena Splendiani, Zaira Spinello, Silvia Cantara, Patrizia Zavattari, Eleonora Loi, Cristina Romei, Raffaele Ciampi, Luciano Pezzul
  Biomarker Research.2023;[Epub]     CrossRef
• Advances in Diagnostics and Therapy of Medullary Thyroid Carcinoma (MTC)– A Mini-Review
  Michał Miciak, Krzysztof Jurkiewicz
  Clinical Cancer Investigation Journal.2023; 12(5): 1.     CrossRef
• The Evolving Treatment Landscape of Medullary Thyroid Cancer
  Marta Laganà, Valentina Cremaschi, Andrea Alberti, Danica M. Vodopivec Kuri, Deborah Cosentini, Alfredo Berruti
  Current Treatment Options in Oncology.2023; 24(12): 1815.     CrossRef
• Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers
  Faraat Ali, Kumari Neha, Garima Chauhan
  Archives of Pharmacal Research.2022; 45(5): 309.     CrossRef
• Psychosocial Characteristics and Experiences in Patients with Multiple Endocrine Neoplasia Type 2 (MEN2) and Medullary Thyroid Carcinoma (MTC)
  Robin Lockridge, Sima Bedoya, Taryn Allen, Brigitte Widemann, Srivandana Akshintala, John Glod, Lori Wiener
  Children.2022; 9(6): 774.     CrossRef
• Aggressive clinical course of medullary thyroid microcarcinoma
  Tamara Janić, Mirjana Stojković, Sanja Klet, Bojan Marković, Beleslin Nedeljković, Jasmina Ćirić, Miloš Žarković
  Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma.2022; 27(85): 63.     CrossRef
• Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies
  Max Czajkowski, Daniel Kaemmerer, Jörg Sänger, Guido Sauter, Ralph M. Wirtz, Stefan Schulz, Amelie Lupp
  BMC Cancer.2022;[Epub]     CrossRef
• Metastatic Risk Stratification of 2526 Medullary Thyroid Carcinoma Patients: A Study Based on Surveillance, Epidemiology, and End Results Database
  Minh-Khang Le, Masataka Kawai, Toru Odate, Huy Gia Vuong, Naoki Oishi, Tetsuo Kondo
  Endocrine Pathology.2022; 33(3): 348.     CrossRef
• Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
  Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, Agnieszka Mikuła, Maria Greniuk, Jerzy Rudnicki
  Cancers.2022; 14(15): 3643.     CrossRef
• Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
  Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, Federica Campolo, Tullio Florio, Nevena Mikovic, Alice Plebani, Valentina Di Vito, Annamaria Colao, Antongiulio Faggiano
  Cancers.2022; 14(16): 3991.     CrossRef
• Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
  Davide Saronni, Germano Gaudenzi, Alessandra Dicitore, Silvia Carra, Maria Celeste Cantone, Maria Orietta Borghi, Andrea Barbieri, Luca Mignani, Leo J. Hofland, Luca Persani, Giovanni Vitale
  Cancers.2022; 14(18): 4442.     CrossRef
• Rapid and long-lasting response to selpercatinib of paraneoplastic Cushing’s syndrome in medullary thyroid carcinoma
  Marine Sitbon, Porhuoy Chou, Seydou Bengaly, Brigitte Poirot, Marie Laloi-Michelin, Laure Deville, Atanas Pachev, Ahouefa Kowo-Bille, Clement Dumont, Cécile N Chougnet
  European Thyroid Journal.2022;[Epub]     CrossRef
• [Retracted] Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib‐Induced QT Interval Prolongation
  Juan Zhang, Dan Luo, Fang Li, Zhiyi Li, Xiaoli Gao, Jie Qiao, Lin Wu, Miaoling Li, Shao Liang
  Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
• THE ROLE OF CALCITONIN IN THE PREOPERATIVE STAGE AS THE PREDICTOR OF MEDULLARY THYROID CANCER METASTASES
  Volodymyr Palamarchuk , Viktor Smolyar , Oleksandr Tovkay, Oleksandr Nechay, Volodymyr Kuts , Revaz Sichinava , Oleh Mazur
  Ukrainian Scientific Medical Youth Journal.2021; 127(4): 68.     CrossRef
• THE ROLE OF CALCITONIN IN THE PREOPERATIVE STAGE AS THE PREDICTOR OF MEDULLARY THYROID CANCER METASTASES
  Volodymyr Palamarchuk , Viktor Smolyar , Oleksandr Tovkay , Oleksandr Nechay , Volodymyr Kuts , Revaz Sichinava , Oleh Mazur
  The Ukrainian Scientific Medical Youth Journal.2021; 4(127): 68.     CrossRef